Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Completed - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Completed - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Biological: MK-8808 500 mg/m^2; Biological: Rituximab 500 mg/m^2; Drug: Methotrexate; Biological: MabThera (rituximab) 500 mg/m^2; Biological: Rituxan...

Condition : Rheumatoid Arthritis Interventions : Biological: MK-8808; Biological: Rituximab; Drug: methotrexate Sponsor : Merck Recruiting - verified August 2011

This study will evaluate the potential effect of CP 690,550 on the pharmacokinetics of metformin, a probe drug for organic cationic transport.

Condition : Gout Intervention : Drug: Allopurinol Sponsor : Ardea Biosciences, Inc. Recruiting - verified August 2011

Conditions : Degenerative Joint Disease; Osteoarthritis Interventions : Other: EACA; Other: Placebo arm Sponsor : Mayo Clinic Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Biological: MK-8808; Biological: Rituximab; Drug: methotrexate Sponsor : Merck Recruiting - verified August 2011

This study will evaluate the potential effect of CP 690,550 on the pharmacokinetics of metformin, a probe drug for organic cationic transport.